Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 771-776

  Lukomski, Slawomir ^a   Burns Jr , Eugene H ^a,c   Wyde, Philip R ^a   Podbielski, Andreas ^b   Rurangirwa, Jacqueline ^a   Moore Poveda, Donna K ^a   Musser, James M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c DREW UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MUTATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; ENZYME INACTIVATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PYOGENES;

EID: 0031906945     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.771-776.1998     Document Type: Article

References (33)

1. Berge, A., and L. Bjorck. 1995. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J. Biol. Chem. 270:9862-9867.
2. Burns, E. H., Jr., A. M. Marciel, and J. M. Musser 1996. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect. Immun. 64:4744-4750.
3. Dale, J. B., R. G. Washburn, M. B. Marques, and M. R. Wessels. 1996. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 64:1495-1501.
4. Elliott, S. D. 1945. A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type-specific M antigen. J. Exp. Med. 81:573-592.
5. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
6. Golstein, P., and H. Biomgren. 1973. Further evidence for autonomy of T-cell mediating specific in vitro cytotoxicity: efficiency of very small amounts of highly purified T cells. Cell. Immunol. 9:127-141.
7. Gubba, S., D. E. Low, and J. M. Musser. 1998. Expression and characterization of group A Streptococcus extracellular cysteine protease recombinant mutant proteins and documentation of seroconversion during human invasive disease episodes. Infect. Immun. 66:765-770.
8. Herwald, H., M. Collin, W. Muller-Ester, and L. Bjorck. 1996. Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J. Exp. Med. 184:1-9.
9. Hirsch, J. G., and A. B. Church. 1960. Studies of phagocytosis of group A streptococci by polymorphonuclear leukocytes in vitro. J. Exp. Med. 111:309-322.
10. Holm, S. E., A. Norrby, A. M. Bergholm, and M. Norgren. 1992. Aspects of pathogenesis of serious group A Streptococcal infections in Sweden, 1988-1989. J. Infect. Dis. 166:31-37.
11. Ji, Y., L. McLandsborough, A. Kondagunta, and P. P. Clean. 1996. C5a peplidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64:503-510.
12. Kapur, V., J. T. Maffei, R. S. Greer, L.-L. Li, G. J. Adams, and J. M. Musser. 1994. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathog. 16:443-450.
13. Kapur, V., M. W. Majesky, L.-L. Li, R. A. Black, and J. M. Musser. 1993. Cleavage of interleukin 1 β(IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 90:7676-7680.
14. Kapur, V., S. Topouzis, M. W. Majesky, L.-L. Li, M. R. Hamrick, R. J. Hamill, J. M. Patti, and J. M. Musser. 1993. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb. Pathog. 15:327-346.
15. Lancefield, R. C. 1962. Current knowledge of type-specific M antigens of group A streptococci. J. Immunol. 89:307-313.
16. Lukomski, S., S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J. M. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99:2574-2580.
17. Musser, J. M. 1997. Streptococcal superantigen. mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function, p. 281-310. In D. Y. M. Leung, B. T. Huber and P. M. Schlievert (ed.), Superantigens. Molecular biology, immunology, and relevance to human disease. Marcel Dekker, Inc., New York, N.Y.
18. Norgren, M., M. G. Caparon, and J. R. Scott. 1989. A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6,1 allele in Streptococcus pyogenes JRS4. Infect. Immun. 57:3846-3850.
19. Pantazis, C. G., and W. T. Kniker. 1979. Assessment of blood leukocyte microbial killing by using a new fluorochrome microassay. J. Reticuloendothel. Soc. 26:155-170.
20. Perez-Casal, J., M. G. Caparon, and J. R. Scott. 1992. Introduction of the emm6 gene into an emm-deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis. Res. Microbiol. 143:549-558.
21. Perez-Casal, J., J. A. Price, E. Maguin, and J. R. Scott. 1993. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol. Microbiol. 8:809-819.
22. Phillips, H. J., and J. E. Tarryberry. 1957. Counting actively metabolizing tissue culture cells. Exp. Cell Res. 13:341-347.
23. Podbielski, A., N. Schnitzler, P. Beyhs, and M. D. P. Boyle. 1996. M-related protein (Mrp) contributes to group A Streptococcal resistance to phagocytosis by human granulocytes. Mol. Microbiol. 19:429-441.
24. Schrager, H. M., J. G. Rheinwald, and M. R. Wessels. 1996. Hyaluronic acid capsule and the role of Streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Invest. 98:1954-1958.
25. Simor, A. E., L. Louie, B. Schwartz, A. McGeer, S. Scriver, the Ontario GAS Study Project, and D. E. Low. 1993. Association of protease activity with group A Streptococcal (GAS) necrotizing fasciitis (NF), abstr. 1164. In Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Stamp, T. C., and E. B. Hendry. 1937. The immunizing activity of certain chemical fractions isolated from haemolytic streptococci. Lancet 1:257-259.
27. Todd, E. W. 1947. A study of the inhibition of Streptococcal proteinase by sera of normal and immune animals and of patients infected with group A hemolytic streptococci. J. Exp. Med. 85:591-606.
28. Wessels, M. R., J. B. Goldberg, A. E. Moses, and T. J. DiCesare. 1994. Effects on virulence of mutations in a locus essential for hyuluronic acid capsule expression in group A streptococci. Infect. Immun. 62:433-441.
29. Wessels, M. R., A. E. Moses, J. B. Gold berg, and T. J. DiCesare. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA 88:8317-8321.
30. Wexler, D. E., D. E. Chenoweth, and P. P. Cleary. 1985. Mechanism of action of the group A Streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA 82:8144-8148.
31. Whatmore, A. M., V. Kapur, D. J. Sullivan, J. M. Musser, and M. A. Kehoe. 1994. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol. Microbiol. 14:619-631.
32. Whitnack, E., A. L. Bisno, and E. H. Beachey. 1981. Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect. Immun. 31:985-991.
33. Wolf, B. B., C. A. Gibson, V. Kapur, I. M. Hussaini, J. M. Musser, and S. L. Gonias. 1994. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J. Biol. Chem. 269:30682-30687.